To the Editor:
We thank The Journal for this opportunity to restate some of the findings in our report1.
One of our conclusions is that antiphosphatidylserine/prothrombin (aPS/PT) is associated with thrombosis in systemic lupus erythematosus (SLE), agreeing with the data published by Bertolaccini, et al2. We completely agree that aPS/PT should be …
Address correspondence to Dr. M. Petri, Johns Hopkins University, Rheumatology, 1830 E. Monument Street, Suite 7500, Baltimore, MD 21205, USA., E-mail: mpetri{at}jhmi.edu